Table 1.
compound | structure | % inhibition at 20 µM deprotonation | IC50 (µM) NADPH oxidation |
---|---|---|---|
PBCV-1 ThyX | |||
C8-C1 2-hydroxy-3-(4-methoxybenzyl)-1,4-naphthoquinone |
78 ± 4 | 4.5 | |
E11-C1 2-hydroxy-3-(2-oxo-2-phenylethyl)-1,4-naphthoquinone |
36 ± 5 | 11.0 | |
H3-C1 2-hydroxy-3-(2-oxo-2-(thiophen-2-yl)ethyl)-1,4-naphthoquinone |
38 ± 3 | 7 | |
F3-C1 2-hydroxy-3-(2-oxo-2-p-tolylethyl)-1,4-naphthoquinone |
38 ± 7 | 7 | |
G3-C1 2-hydroxy-3-(2-(4-methoxyphenyl)-2-oxoethyl)-1,4-naphthoquinone |
22 ± 7 | 10 | |
B3-C1 2-(5-hydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-ylamino)benzoic acid |
12 ± 6 | >10 |